Cell Therapy Preclinical Safety Programs: Cost-Effective Approaches to Biodistribution Employing Adv

Sep 18 2012

In this webinar, Charles River experts in pathology, immunohistochemistry, molecular biology, toxicology and regulation discuss comprehensive methods of preclinical study that answer crucial questions of safety and efficacy while streamlining programs to reduce up-front costs. We highlight the early study of cell fate (pilot biodistribution study), which serves many important functions, including determining model feasibility and how long cells reside in the body.

Presenters

• Dr. Shawna Jackman, Senior Research Scientist, Photobiology and Cellular Therapeutic Safety
• Julia F.M. Baker, Staff Pathologist, Medical Device Division
• Mary McElroy, Senior Study Director, Inhalation Toxicology
• Curtis Chan, BA, Director, Pathology Services